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This report builds on the authors' earlier discov-
ery of bis(5-amidino-2-benzimidazolyl)methane
(BABIM) as a strong suppressive agentfor strepto-
coccal cell wallfragment-induced arthritis in the
Lewis rat. As a synthetic inhibitor of trypsinlike
proteases, BABIM opens up a new route to the con-
trol ofinflammatoryjoint disease. To gain a deeper
insight into thefunction of the compound, the au-
thors have now studied its influence on the sequen-
tial development ofthejoint changes and the asso-
ciated lesions in spleen and liver. Bis(5-amidino-2-
benzimidazolyl)methane is shown to block acute
synovitis, to retard and reduce granuloma forma-
tion in spleen and liver, to decrease neutrophilic
leukocytosis, and to diminish hemopoietic hyper-
plasia in the bone, and thus also to mitigate the dis-
tinctive osteoclastic and chondroclastic events.
The compound does not interfere with the splenic
immune response, the temporary rise in hepato-
cytic mitotic activity, or the organ deposition of
streptococcal cell walls. (Am J Pathol 1990, 136:
909-921)
Previously, we have shown that treatment with the potent
protease inhibitor bis(5-amidino-2-benzimidazolyl)meth-
ane (BABIM) can improve significantly the clinical signs
and morphologic abnormalities of experimental arthritis in
the Lewis rat.' In that study, inflammation was induced by
systemic application of streptococcus group A cell-wall-
derived peptidoglycan polysaccharide (PG-APS) and all
animals were killed at the same time, 19 days after initia-
tion of the arthritis. Animals treated with intravenous appli-
cation of BABIM had a striking reduction in the severity of
their synovitis and their destructive lesions in ankle and
foot bones. There also was a marked decrease in the
number of granulomata, which are found in the liver of
Lewis rats as a characteristic response to PG-APS. Fur-
thermore, it was noted that osteitis was always accompa-
nied by replacement of the fatty marrow by trilineage he-
mopoietic hyperplasia, although it remained unresolved if
inflammation preceded hyperplasia or vice versa. Regard-
less of the actual sequence, BABIM mitigated both those
processes.
Bis(5-amidino-2-benzimidazolyl) is a strong inhibitor of
trypsin, thrombin, plasmin, and urokinase.23 Inhibition of
those enzymes or of related arginyl- and lysyl-directed
esteroproteases is held responsible for its ability to block
replication of respiratory syncytial virus and rotavirus and
to reduce tumor invasion and metastases.4- As the drug
now also offers a new approach to the treatment of arthri-
tis and holds considerable promise for use in humans,
it becomes imperative to investigate in greater detail the
histologic aspects of the arthritis model. To this end, the
progress of the disease and its modulation by BABIM
have now been followed at close time intervals, and spe-
cial attention has been directed toward the development
of lesions in synovium, bone, spleen, and liver and toward
changes in the circulating white blood cell count. The re-
sults, as presented here, have made it possible to arrange
the pathologic events in a predictable sequence and to
pinpoint the sites of interference of BABIM with those pro-
cesses.
Materials and Methods
Streptococcal Cell Wall Fragments
The material was prepared as previously described in de-
tail.9 In brief, group A beta-hemolytic streptococci (type 3,
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strain D-58) were harvested and washed by continuous-
flow centrifugation. The cells were disrupted in a Braun
homogenizer. The cell walls were separated by differential
centrifugation, purified by repeated extraction with 2% so-
dium dodecyl sulfate and then dialyzed and freeze-dried.
The purified cell walls were suspended in phosphate-
buffered saline, dispersed by sonication, and centrifuged
at 10,000g for 30 minutes. The fragments in the superna-
tant were filtered through a 0.45-i Millipore membrane
and injected intraperitoneally.
Quantitation of Streptococcal
Cell Wall in Tissue
An established enzyme-linked immunosorbent assay was
used to quantitate the amount of PG-APS in rat liver and
spleen.10 Tissue samples were homogenized in TRIS
buffer for 30 seconds with a Sonifier Cell Disruptor (Bran-
son Sonic Power Group). The samples were microfuged
for 2 minutes in a Fisher microcentrifuge, and superna-
tants of the extracts were assayed. The extracts, after
suitable dilution, were added to 96-well microtiter plates
previously coated with affinity-purified anti-group A anti-
body. Biotinylated affinity-purified anti-group A antibody
then was added, followed by avidin-alkaline phosphatase.
The color reaction was developed using p-nitrophenyl
phosphate substrate, and the optical density was deter-




Synthesis of the inhibitor has been described in an earlier
publication.2 Purity of the compound was greater than
99.6%. The formula of the preparation used was
C17H16N4/4.3 HCI/1.7 H20, including 64% by weight of
the active principle. For injection into the rats, solutions of
the material in isotonic saline were prepared fresh on a
daily basis.
Treatment of Animals
Inbred female Lewis rats weighing 145 g were obtained
from Charles River Breeding Laboratories (Wilmington,
MA). They had unlimited access to regular laboratory
chow and water. Arthritis was initiated by a single intra-
peritoneal injection of 0.5 ml of the streptococcal cell wall
material (PG-APS) described above. The amount of PG-
APS given to each animal was equal to 15 ,ug of rhamnose
content per gram of body weight. Half the number of ani-
mals received daily injections of BABIM dissolved in 0.5
ml saline, while the other half received saline only. Appli-
cation was into the tail vein under light ether anesthesia.
Histologic Methods
Death of the animals was by an overdose of ether. Imme-
diately afterwards, the liver and spleen were removed and
weighed. Aliquots of each organ were frozen and saved
for PG-APS determination, while the rest was fixed in
buffered formalin. The hind legs were skinned and were
also submitted. Following fixation, they were decalcified
in formic acid-sodium citrate solution. All tissues were em-
bedded in paraffin and stained with hematoxylin and eosin
as well as with periodic acid-Schiff (PAS) after diastase
digestion. To determine the density of the granulomata in
the liver, it was necessary to measure the area of the liver
sections. This was done with the help of a Zeiss Video-
plan computer image analyzer (Carl Zeiss, West Ger-
many).
Clinical Evaluation of Arthritis
The extent of the arthritic process was judged on a daily
basis and scored as a number.11 Involvement of front and
hind legs was determined and rated for each extremity on
a scale of 0 to 4, making possible a maximal grade of 16.
Only observations on the wrist and ankle joints and the
tissues distal from there were taken into consideration.
Evaluation involved the degree of cutaneous erythema
and soft tissue edema as well as the severity of joint swell-
ing and deformity.
Histologic Scoring of Arthritis
To rank the histologic changes, attention was centered
on the synovium of the talocrural joint and on the distal
tibia and the calcaneus. In the synovium, the following
features were looked for; lining cell hyperplasia, edema,
fibrin deposits, acute and chronic inflammatory cells, joint
exudate, and capillary and fibroblastic proliferation. In the
bones, evaluation was focussed on the degree of hemo-
poietic hyperplasia, osteoclasia and chrondroclasia, neu-
trophilic infiltration, fibrosis and new bone formation, and
the destruction of cortical bone, epiphyseal plates, and
joint cartilage. The highest attainable score was 15.
White Blood Cell Count
Total white blood cell counts were determined with the
help of a Baker cell counter (Baker Instruments) on heart
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blood anticoagulated with EDTA. White blood cell differ-
ential counts were carried out on blood smears stained
with Wright's stain. A total of 100 cells were counted and
the types were identified by morphology.
Statistical Analysis
Student's t-test was employed to evaluate the statistical
significance of the difference between two means.
Results
The experimental approach can be briefly summarized as
follows: Lewis rats with PG-APS-induced disease re-
ceived a daily intravenous injection of either BABIM or of
the saline vehicle. The dose was 10 mg/kg body weight
of the preparation specified above. Administration of the
compound began 2 days before the induction of arthritis
and ended 24 hours before death. For logistical reasons,
the experiment was run in two stages, the first furnishing
data from day 0 through day 5 and the second from day
6 through day 14. As all conditions were closely matched,
there was a nearly seamless transition between the two
sets of data.
Joints and Bones
The clinical and the histologic severity of the joint disease
is demonstrated in Figure 1A and Figure 1 B, respectively.
The clinical scores represent the mean values for all
treated or untreated animals remaining on a given day,
while the histologic scores represent the mean values of
those treated or untreated animals killed on a given day.
The animals werp usually killed in groups of four. The only
exception was at day 14, when there were five animals to
either group. From the graphs, it is evident that inflamma-
tion in the control animals was well established by day 1
and that it became more pronounced as time progressed.
The figures also make it clear that BABIM was remarkably
effective in mitigating the pathologic events throughout
the length of the experiment.
Histologically, the first changes in the BABIM-free ani-
mals appeared in the synovium of the talocrural joint and
then spread to the other, more distal joints of the foot. In
the day 1 specimen from the ankle joint, there were noted
synovial lining cell hypertrophy and hyperplasia, fibrin de-
position on top of the lining cells and on areas of lining
cell loss, and a scant neutrophilic infiltrate in the stroma.
The synovial recess was dilated and the lumen contained
small numbers of neutrophils. At day 2, neutrophils had
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Figure 1. Clinical (A) and histologic (B)jointscores in BABIM-
treated (--) and vehicle-treated (-0-) Lewis ratsfollowed
for2 weeks after PG-APS injection. At24 hours and at allpoints
beyond, the differences between the two series were statisti-
cally significant (P < 0. 05) in both scoring systems.
was dilatation of venules and capillaries and marked soft
tissue edema. Small groups of lymphocytes were ob-
served for the first time. Many of the hyperplastic synovial
cells now showed cytoplasmic vacuolization. At days 3
and 4, there was the added feature of fibroblastic and
capillary proliferation. Edema had decreased at day 5, as
had the number of neutrophils. Fibroblasts began to lay
down collagen. At day 6, stromal cell proliferation per-
sisted and small numbers of lymphocytes were still en-
countered. By day 9, neutrophils began to make a come-
back, and they achieved their most massive infiltration on
days 12 and 14. It should be added that similar findings
as those just described for the joint synovium were en-
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Figure 2. Synovium oftalocruraljoint in Lewis rats 14 days after systemic PG-APS injection. A: Absence ofinflammation in BABIM-
treated animal. B: Marked acute inflammation in vehicle-treated animal (H&E, X 100).
countered also in the tendon sheaths of the lower leg and
the bursa of the Achilles tendon.
A comparison of the synovial changes in BABIM-
treated animals with those in the controls confirmed the
suppressive activity of the compound (Figure 2). From all
aspects of PG-APS-induced disease, synovitis seems to
be the condition most susceptible to inhibition. In the ma-
jority of treated rats, inflammation was completely absent,
while in the others its severity was greatly reduced. In the
latter cases, it appears that none of the various histologic
expressions of the inflammatory process in the synovium,
such as lining cell hyperplasia, edema, or neutrophilic in-
filtration, was more effectively countered than any other.
After synovitis, the next most important pathologic ab-
normality in the hind legs was related to the bones them-
selves. In the untreated animals, there was a stereotyped
unique set of events that began in the distal tibia and
spread within a week to also involve the tarsal and meta-
tarsal bones. The initial occurrence, starting 3 days into
the experiment, was an increase in hemopoietic elements
in the marrow cavity of the distal tibial diaphysis, and in
the metaphysis and epiphysis. Fat cells, which normally
make up 80% or more of the marrow, were being replaced
by erythroid, myeloid, and megakaryocytic cell lines in all
stages of maturation (Figure 3). At day 9, complete re-
placement had been achieved. As early as day 3, and
always in association with increased hemopoietic activity,
there was the appearance of osteoclasts within the me-
taphyseal region. The cells were arranged singly or in
clusters and were commonly accompanied by groups of
mature neutrophils. The neutrophils often were closely
packed into Howship's lacunae together with the osteo-
clasts (Figure 4). After 7 days, osteoclasia was seen in all
animals, and it proceeded at a rapid pace to destroy corti-
cal as well as medullary bone. Epiphyseal bone also be-
came victim of the onslaught, and finally there was disso-
lution of the epiphyseal plate from both its sides and ero-
sion of the joint cartilage from the subchondral marrow
spaces (Figures 5B and C). In the areas of active os-
teoclasia, hemopoietic elements usually disappeared and
left behind the fibrovascular framework with an infiltrate
of varying numbers of mature neutrophils. Finally, after
completion of the bone destruction, reparative processes
came into play, consisting of stromal proliferation and
new bone formation. Proliferation also was encountered
in the periosteum, often associated with osteoblastic ac-
tivity.
Under the influence of BABIM treatment, there was a
delay of the appearance of hemopoietic hyperplasia of
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Figure 3. Bone marrow cavity in distal tibial shaft in Lewis rats 7 days after PG-APS injection. A: Predominantly fatty marrow in
BABIM-treated animal. B: Marked trilineage bemopoietic hyperplasia in vehicle-treated animal (H&E, X 100).
about 3 days, and there also was a delay and significant
amelioration of all the other pathologic changes described
for the bones (Figure 5A). Numerically, the degree of im-
provement by BABIM is best reflected by the histologic
scores in Figure 1 B, where 1 1 points out of a possible 15
were allocated to rank the various bone lesions.
Spleen
The first histologic changes in the spleen, as observed at
6 hours after PG-APS injection, consisted of deposits of
PAS-positive material, presumably streptococcal cell wall
fragments.12 The material appeared finely granular and
was located in macrophages in the marginal zone and in
the red pulp. Subsequent to its accumulation, three dis-
tinct reaction patterns evolved: a granulomatous process,
a non-specific immune response, and a proliferation of
hemopoietic elements. Granulomata were in evidence as
early as at 24 hours. They could be recognized as aggre-
gates of typical epithelioid cells in the marginal zone,
where they became associated with increasing numbers
of neutrophils. Number and size of the granulomata rap-
idly increased and large central areas of necrosis devel-
oped. At 9 days, 60 to 80% of the white and red pulp were
destroyed and the initially spherical shape of many of the
granulomata had changed into an irregular geographic
pattern (Figure 6). The ramifying central stretches of non-
viable tissue were replete with neutrophils. They were sur-
rounded by epithelioid cells and histiocytes, and those
again were enveloped by fibroblasts. Beyond day 9, colla-
gen was being laid down at the periphery of the granulo-
mata, and the centers appeared to shrink because of to
removal of the necrotic debris. This led to a relative in-
crease in nongranulomatous parenchyma, so that the his-
tologic sections looked less abnormal than they had just
a few days earlier. Ascendancy and decline in granuloma-
tous involvement are reflected in the remarkable rise and
fall of the spleen weights, as shown in Figure 7. As is to
be expected with any injection of antigenic foreign mate-
rial, the spleen also developed an acute immune re-
sponse. At day 4, immunoblasts and plasma cells were
found clustered in the red pulp, and at days 6 and 7 they
were very prominent. There also was a brief appearance
of germinal centers, many of them distinguished by tangi-
ble body macrophages.
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Figure 4. Neutrophil-assisted osteoclasia in distal tibial metaphysis in vehicle-treatedLewis rat 14 days afterPG-APS injection. Char-
acteristic grouping ofneutrophils with osteoclasts (arrows) in Howship 's lacunae (H&E, X540).
The plasma cell infiltration came to a rather precipitous
end, when at day 9 all the red pulp became solidly packed
with hemopoietic elements of the erythroid, myeloid, and
megakaryocytic cell lines. This situation remained un-
changed through the final day of the experiment.
An evaluation of the various splenic responses in vehi-
cle-treated and BABIM-treated animals brought to light
one significant difference. This was a delay in the appear-
ance of the granulomata in the latter series and a reduc-
tion in their number, as determined from counts on whole
transverse sections of the spleens (Table 1). Beyond day
5, however, granulomatous involvement evened out be-
tween the two series. Immune reactivity, as expressed by
plasma cell and lymphocytic infiltrates in the red pulp, and
degree of hemopoiesis were not affected by the drug.
There was no influence of BABIM on the spleen weights
(Figure 7).
Liver
In the liver, there occurred two PG-APS-related events
that deserve attention; a burst in mitotic activity and the
formation of granulomata. An increased rate of division in
the hepatic parenchymal cells was detected during rou-
tine examination of the histologic sections, and the initial
impression was confirmed by quantitation. For each liver
specimen, the total number of mitoses in 40 consecutive
high-power fields (X 450) was established. As is demon-
strated in Figure 8, the mitotic count became sharply ele-
vated at days 6, 7, and 9 and then returned to normal. It
is also evident that the liver weights rose in concert with
the mitotic activity, suggesting that parenchymal hyper-
plasia probably was responsible for the weight gain. It
should be noted that the mitotic figures seen were from
all phases of the replication cycle. This makes it unlikely
that mitotic "arrest" was producing a false impression of
increased mitotic activity. Finally, the closeness of the mi-
tosis data for BABIM-treated and control animals allows
the conclusion that cell division was not affected by the
test compound.
Periodic acid-Schiff-positive material appeared in the
periportal Kupffer cells of the liver as early as it did in the
macrophages of the spleen, ie, at 6 hours after PG-APS
injection. However, the granulomatous reaction took a
week longer to express itself in the liver than in the spleen.
Only at day 12 was the process well under way. Granulo-
mata developed preferentially in the portal areas, but
some also originated around central or sublobular veins
or within the lobules. The lesions began as small groups
of epithelioid cells surrounded by a rim of lymphocytes,
scattered neutrophils, and PAS-positive non-Kupffer cell
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Figure 5. Sections ofdistal tibia including, from top to bottom,
distal metaphysis, epiphyseal plate, epipbysis, andjoint carti-
lage. A: BABIM-treated animal 7 days after PG-APS injection.
No pathologic changes. B: Vehicle-treated animal 7 days after
PG-APS injection. Extensive destruction ofmetaphyseal bone,
epiphysealplate, and epiphyseal bone, andfocal disruption of
joint cartilage. C: Vehicle-treated animal 14 days afterPG-APS
injection. Complete replacement ofmetaphyseal bone, epiphy-
seal plate, and epiphyseal bone by loose fibrovascular tissue
with scattered neutrophils. Degeneration and focal ossifica-
tion ofjoint cartilage (H&E, X 100).
916 Geratz et al
AJPApril 1990, Vol 136, No. 4
Figure 6. Splenic granulomatous disease. A: Spherical granuloma in vehicle-treated rat 14 days after PG-APS injection. The sharply
demarcated lesion consists chiefly ofepithelioid cells and has a necrotic center containing degenerating neutrophils. Hemopoietic
elements arepresent in the redpulp bordering on the granuloma (H&E, X 100). B: Confluent necrosis in vehicle-treated rat 12 days
after PG-APS injection. An irregular band of necrosis extendsfrom top to bottom through the center of the field and isframed by
layers ofpale-staining epithelioid cells. Along the right and left borders of the field there are small amounts ofpreserved redpulp
infiltrated by hemopoietic cell nests (H&E, X40).
macrophages. They enlarged by acquiring more epitheli-
oid cells, and beyond a certain size they experienced a
heavy influx of neutrophils and subsequent central necro-
sis. There was, however, a distinct difference in the pro-
gression of the granulomata between the BABIM-treated
and the saline control animals (Table 2). Although equal
numbers of hepatic lesions were encountered in the two
series at day 12, there was a disparity in their size. All
granulomata in the BABIM series were small, while in the
controls, 17.4% of the lesions exceeded a diameter of
[fr1/2] high-power field at X 450 and were classified as
macrogranulomata. Those larger granulomata also were
the ones with central neutrophils and necrosis (Figure 9).
At day 14, the difference between the two series of ani-
mals had become more pronounced. There still were no
macrogranulomata in drug-exposed rats, and the total
number of granulomata had actually fallen. In contrast,
the number of granulomata in the controls had more than
doubled, as had the percentage of macrogranulomata.
It is likely that the increasing divergence of liver weights
between the series at days 12 and 14 (Figure 8) was a
reflection of the different degrees of severity of the granu-
lomatous involvement.
Circulating White Blood Cells
Injection of PG-APS into the Lewis rats provoked a
marked leukocytosis. Neutrophils and monocytes experi-
enced a greater relative increase than lymphocytes, but in
absolute numbers all three cell lines reached similar peak
values (Figure 10).
In the lymphocyte series, the counts rose continuously
during the first week and leveled off during the second
week. Shape and height of the graphs were not signifi-
cantly different between the vehicle-treated and the BAB-
IM-treated groups (Figure 1 OA). Monocyte numbers
peaked between 7 and 9 days and tended to fall during
the second week (Figure 1 OB). While the fall was unbro-
ken for the drug-treated series, the untreated series re-
bounded between 12 and 14 days and ended up with a
count significantly higher than the BABIM-treated animals.
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Figure 7. Spleen weights in BABIM-treated (-0-) and vehicle-
treated (-0-) ratsfollowedfor two weeks after PG-APS injec-
tion. All groups consisted offour animals, exceptfor the day-
14 groups which were made up offive animals. The differences
between the two series ofanimals were not statistically signifi-
cant (P > 0.05).
With regard to the neutrophils, the untreated animals
showed a progressive increase through both weeks,
while the treated animals demonstrated a continuous de-
cline after the first week (Figure 10C). At 14 days, the
difference between the two sets of animals was highly
significant.
Deposition of PG-APS in Spleen and Liver
To determine if differences in the deposition of strepto-
coccal cell wall fragments could have accounted for the
different histologic lesions observed in BABIM-treated and
vehicle-treated animals, amounts of PG-APS were mea-
sured in liver and spleen. On examining the results in Fig-
ure 11, it is evident that there was no significant discor-
dance between the findings in the two series of animals.
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Figure 8. Liver weights and liver mitosis counts in BABIM-
treated (-0-) and vehicle-treated (-0-) rats followedfor 2
weeks after PG-APS injection. All groups consisted offour ani-
mals, exceptfor the day-14 groups which were made up offive
animals. Liver weights were significantly different between the
two series on days 12 and 14. For the mitosis count, the day- 7
value for the BABIM-treated animals and the day-6, day- 7,
and day-9 valuesfor the vehicle-treated animals were signifi-
cantly different (P < 0.05) from the preceding day-3, day-4,
and day-5 values.
As expected from the histologic studies, organ deposition
of PG-APS was well under way at 6 hours after injection
of the material. In the spleen, the values peaked after 2
days and leveled off during the second week. In the liver,
the values for the BABIM-treated animals also reached
their highest level at 2 days, while the vehicle-treated ani-
mals had already experienced their peak a day earlier. As
the size of the liver deposits for the two series of rats was
well matched at all other points, the importance of the
initial discrepancy remains uncertain at this point. Future
studies may reinvestigate this aspect for confirmation.
However, it is interesting that the PG-APS deposits in the
liver rose to a second peak early in the second week of
the experimental period. One wonders if the early steps
in the digestion of PG-APS by Kupffer cells could have
Table 1. Effect ofBABIM on the Occurrence ofSplenic Granulomata in the Early Post-PG-APS Injection Period
Number of granulomata per splenic sectiont
Days after injection of PG-APS
Treatment* 1 2 3 4 5
BABIM 0 0 0.13 ± 0.25 0.25 ± 0.5 2.0 ± 3.02t
Saline 0 1.38 ± 1.2 0.75 ± 0.87 2.60 ± 2.40 7.5 ± 3.43
* n = 4 for either group at each point.
t Granulomata were counted in two spleen sections per animal. Values are means ± SD.
t P < 0.05 against saline control.
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Table 2. Effect ofBABIM on the TotalNumber ofGranulomata and the Percentage ofMacrogranulomata
in Sections ofLiver
Days after PG-APS injection
12 14
Granulomata Macrogranulomata Granulomata Macrogranulomata
Treatment* (no./100 mm2) (% of total) (no./100mm2) (% of total)
BABIM 40.5 ± 23.9 0 30.4 ± 8.5t 0
Saline 47.4 ± 21.3 17.1 ± 9.8 107.5 ± 66 34.3 ± 9.3
* For the day-12 group, n = 4; for the day-14 group, n = 5.
t Significantly different from the saline group (P < 0.005). Values are means ± SD.
unmasked additional reactive epitopes and thus pro-
duced a rebound in the ELISA assay.
Comparing the total amounts of PG-APS in the two
organs in Figure 11 makes it obvious that there were
larger deposits in the liver than in the spleen. As the livers
were more than 10 times heavier than the spleens, how-
ever, the concentration of PG-APS in the spleens was
considerably higher than in the livers. This may have been
an additional factor in the earlier occurrence of the granu-
lomatous response in the spleen than in the liver.
Figure 9. Multiple bepatic macrogranulomata in vehicle-
treated rat 14 days after PG-APS injection. All granulomata
shown have central areas ofnecrosis infiltrated by neutrophils
(H&E, X40).
Discussion
The findings of this investigation make it possible to set
up a definite timetable for the series of events taking place
in PG-APS-induced disease in the vehicle-treated Lewis
rat (Table 3). All the reactions listed are thought to repre-
sent responses to local streptococcal cell wall deposition,
which is known to occur within hours after intraperitoneal
injection.'2 The actual type of the lesion and its temporal
constraints then are determined by the microenviron-
ment.
There was a surprising rapidity to the development
and progression of the histologic changes. Thus, acute
synovitis was well established after 1 day, the first splenic
granulomata appeared after the second day, and hemo-
poietic hyperplasia and osteoclasia in the tibia became
evident after 3 days. A seeming discrepancy, however,
existed between the early occurrence of granulomata in
the spleen and their manifestation, much later, in the liver.
The explanation may lie in a difference in antigen process-
ing in the two locations. The macrophages in the marginal
zone of the spleen, a prime antigen trapping site, may be
better equipped for attracting monocytes than the Kupffer
cells in the hepatic sinusoids. In fact, most of the liver
granulomata probably did not develop in association with
Kupffer cells, but in relation to PAS-positive macrophages,
which made a rather late arrival in the portal areas.
It should be noted again that osteoclasia did not occur
by itself, but was always accompanied by hemopoietic
hyperplasia. This suggests a common stimulus for both
events.
The characteristic grouping of neutrophils with the os-
teoclasts has not been previously described. It may repre-
sent a mechanism for enhancement of bone resorption,
in which the neutrophils contribute their degradative en-
zymes to the lytic process. The term "neutrophil-assisted
osteoclasia" seems appropriate for the condition.
At the center of most reactions resulting from PG-APS
injection one probably has to place the stimulated mono-
cyte/macrophage and its cytokines. lnterleukin-1 has al-
ready been shown to be a product of the granulomata
and can be held responsible for attracting neutrophils into
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the center of the lesions and for promoting fibroblastic
proliferation at the periphery.13 Activated macrophages
also have emerged as a controlling force of hemopoiesis,
and they were likely involved with causing the medullary
hyperplasia in the present experiments. In the mouse at
least, bone marrow macrophages have been shown to
release erythropoietin, burst-promoting activity, granulo-
cyte macrophage-stimulating factor, and megakaryocyte-
stimulating activity.14-17 Macrophages also can partici-
pate in an alternative indirect pathway of hemopoietic reg-
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Figure 10. Absolute counts of circulating lymphocytes (A),
monocytes (B), and neutrophils (C) in BABIM-treated ()
and vehicle-treated (-0-) ratsfollowedfor 2 weeks after PG-
APS injection. All groups consisted offour animals, except the
day- 14 groups which were made up offive animals. Values are
means ± SD. Differences between the two series of animals
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Figure 11. PG-APS deposits in spleen (A) and liver(B) in BABIM-
treated (-0-) and vehicle-treated (-0-) rats followedfor 2
weeks after injection of the streptococcal cell wall material.
There were five animals in the day-14 groups. All the other
groups consisted offour animals, with the exception of three
groups with only three animals and one group with only two
animals. Values are means ± SD.
monokines have been shown to bring about secretion of
granulocyte/macrophage growth factor from fibroblasts
and erythroid burst-promoting activity from endothelial
cells.'819 Availability of growth factor probably contrib-
uted to the proliferation of osteoclasts in the bone. Osteo-
clasts are derived from marrow stem cells and share with
the other hemopoietic elements the sensitivity to stimula-
tion by interleukin-3.202' Additional factors, such as os-
teoclast-activating factor and PGE2, may have further pro-
moted the resorptive activity of the osteoclasts.22,23
At this point, it is uncertain what may have caused the
mitotic burst in the liver parenchymal cells. Kupffer cells
may have been involved, because they are known to re-
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Table 3. Chronology ofHistologic Responses to PG-APS Injection
Severity of reaction*
Days after injection
Site Response 1 2 3 4 5 6 7 9 12 14
Synovium Inflammation + ++ +++ +++ +++ +++ +++ +++ ++++ ++++
Tibia Hemopoiesis 0 0 + ++ ++ ++++ ++++ ++++ ++++ ++++
Osteoclasia 0 0 + ++ ++ ++++ ++++ ++++ ++++ ++++
Fibrosis 0 0 0 0 0 0 ++ ++++ ++++ ++++
Spleen Granulomata 0 + + ++ ++ ++++ ++++ ++++ +++ +++
Perigranulomatous fibrosis 0 0 0 0 0 0 + ++ +++ +++
Immune response 0 0 0 + ++ +++ +++ + 0 0
Hemopoiesis 0 0 0 0 0 + + +++ ++++ ++++
Liver Increased mitotic rate 0 0 0 0 0 ++++ ++++ ++++ 0 0
Microgranulomata 0 0 0 0 0 0 0 + ++ ++++
Macrogranulomata 0 0 0 0 0 0 0 0 + ++
Intensity of the response is on a scale from 0 to 4+.
IL-1 and of hepatocyte-stimulating factor,24 and because
a similar response may happen after uptake of PG-APS.
However, neither of the two factors has yet been shown
to increase hepatic cell division, and the reaction time to
their presence should have been measurable in hours
rather than days.
Prolonged leukocytosis has been recognized as a sig-
nificant feature of streptococcal cell wall-induced arthritis
and is thought to be an indicator of persistent disease.25 In
view of the other beneficial effects of BABIM in the arthritis
model, it came as no surprise that the compound would
also cause a reduction in circulating neutrophils and pos-
sibly in monocytes. It was interesting though, that BABIM
did not seem to significantly mitigate neutrophilia during
the first week, at a time when it suppressed inflammatory
cell infiltration in tissues such as synovium. The discrep-
ancy may simply be a statistical aberration due to small
sample size, or it may indicate that different, as yet un-
identified factors govern leukocytosis in the two phases
of the experiment. Increasing neutrophilia in the untreated
animals in the late stage probably was related to the se-
vere granulomatous liver disease evolving at that time.
Animals with BABIM treatment had not only much less
liver involvement, but also a much lesser degree of neu-
trophilia.
As was shown above, the beneficial effects of BABIM
were noted in the joints and bones as well as in the
spleens and livers. The remarkable activity of the com-
pound was not due to interference with the deposition of
PG-APS, because similar amounts were measured in liv-
ers and spleens of treated and untreated animals. Rather,
it seems most plausible that BABIM intervenes in the pro-
cessing of the streptococcal cell wall fragments in the
macrophages or the transmission of signals from those
cells. Points of interference may include, for example, the
plasmin-induced release of interleukin-1 from activated
monocytes26 and the transmembrane signalling in cyto-
toxic T cells, which involves a trypsinlike protease.27
BABIM is unique in its ability to block acute synovitis as
well as in the formation of antigen-induced granulomata,
and it may represent the prototype for drugs effective in
noninfectious granulomatous conditions, such as Crohn's
disease and sarcoidosis.
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